Open muscle biopsy in suspected myopathy: diagnostic yield and clinical utility

Eur J Neurol. 2010 Jan;17(1):136-42. doi: 10.1111/j.1468-1331.2009.02765.x. Epub 2009 Aug 5.

Abstract

Background: The purpose of the study was to investigate the diagnostic yield and clinical utility of open muscle biopsy and to identify pre-biopsy factors that might predict useful clinical results for suspected myopathy.

Methods: Two-hundred fifty-eight muscle biopsies, performed for investigation of suspected myopathy, were evaluated.

Results: A specific clinical diagnosis following muscle biopsy was made in 43% of cases. As a result of the biopsy, clinical diagnosis was changed in 47% and treatment was changed in 33% of cases. Results either led to a specific clinical diagnosis or changed the diagnosis/treatment in 74% of patients. Positive family history of myopathy and findings of myopathic irritability on electromyography had a negative predictive value for diagnosis change.

Conclusions: Open muscle biopsy is useful in myopathy evaluation in the modern genetic era.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Biopsy / methods
  • Biopsy / standards
  • Child
  • Child, Preschool
  • Creatine Kinase / analysis
  • Creatine Kinase / blood
  • Diagnosis, Differential
  • Electromyography
  • Female
  • Genetic Predisposition to Disease
  • Humans
  • Infant
  • Infant, Newborn
  • Male
  • Middle Aged
  • Muscle Weakness / diagnosis
  • Muscle Weakness / etiology
  • Muscle Weakness / pathology
  • Muscle, Skeletal / pathology*
  • Muscle, Skeletal / physiopathology
  • Muscular Diseases / pathology*
  • Muscular Diseases / physiopathology
  • Predictive Value of Tests
  • Retrospective Studies
  • Sensitivity and Specificity
  • Young Adult

Substances

  • Creatine Kinase